EUVIMEDEUVIMED entdecken
Crossref

SRS131 - Establishing national guidance for idiopathic granulomatous MAstitis (ENIGMA)

Shaneel Shah, Leah Argus, Daniel Ahari, Goonj Johri, Rute Castelhano, Claudia MacKean, Vijay Sharma, Rudresh Shukla, Christopher Darlow, Nisha Sharma, Kavita Sethi, Iain Lyburn und 4 weitere

British Journal of Surgery · 27.03.2026 · 113 (Supplement_2)

DOI: 10.1093/bjs/znag018.127 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Surgery, online erschienen am 27.03.2026. Verfasst von Shaneel Shah und 15 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background Idiopathic granulomatous mastitis (IGM) is a rare, benign breast disease characterised by granulomatous inflammation. Current literature mainly comprises of small-sized retrospective studies with no well-designed clinical trials and limited representation of UK population. With no consensus to guide clinical practice there is a significant risk of delayed diagnosis and variation in management strategies that may adversely affect patient outcomes Methods ENIGMA is a multi-stage programme of work aiming to develop guidelines for the diagnosis and management of IGM in the UK. A scoping review will assess the range and quality of existing evidence, focusing on its relevance to UK practice. Findings from this review will inform a national practice questionnaire (NPQ) to capture current approaches to IGM care across the UK. These data, combined with a modified Delphi process involving experts and stakeholders, will support guideline development and help define priority research questions to advance best practice. Progress The scoping review identified 225 papers, involving 13 062 patients, mostly from Turkey, the USA, and China. Only three studies, covering 25 patients, originated from the UK. Commonly reported ethnic groups were Hispanic and Turkish. Risk factors include smoking and hormonal influences such as oestrogen and prolactin. Reported treatment strategies range from conservative approaches to medical therapies (antibiotics, steroids, immunosuppressants) and surgical interventions (drainage or excision). Preliminary results of the NPQ highlight substantial heterogeneity in UK diagnostic and management practices. Once the NPQ analysis is complete, the working group will initiate the Delphi process to establish consensus and inform guideline development.

Zitieren

APA

Shah, S., Argus, L., Ahari, D., Johri, G., Castelhano, R., MacKean, C., Sharma, V., Shukla, R., Darlow, C., Sharma, N., Sethi, K., Lyburn, I., Cox, K., MacInnes, E., Bradley, R., & Kirwan, C. (2026). SRS131 - Establishing national guidance for idiopathic granulomatous MAstitis (ENIGMA). British Journal of Surgery, 113(Supplement_2). https://doi.org/10.1093/bjs/znag018.127

Vancouver

Shah S, Argus L, Ahari D, Johri G, Castelhano R, MacKean C, et al. SRS131 - Establishing national guidance for idiopathic granulomatous MAstitis (ENIGMA). British Journal of Surgery. 2026;113(Supplement_2). doi:10.1093/bjs/znag018.127

BibTeX
@article{Shah2026,
  author = {Shah, Shaneel and Argus, Leah and Ahari, Daniel and Johri, Goonj and Castelhano, Rute and MacKean, Claudia and Sharma, Vijay and Shukla, Rudresh and Darlow, Christopher and Sharma, Nisha and Sethi, Kavita and Lyburn, Iain and Cox, Karina and MacInnes, Emma and Bradley, Roisin and Kirwan, Cliona},
  title = {SRS131 - Establishing national guidance for idiopathic granulomatous MAstitis (ENIGMA)},
  journal = {British Journal of Surgery},
  year = {2026},
  volume = {113},
  number = {Supplement_2},
  doi = {10.1093/bjs/znag018.127}
}
Kostenlos starten →